Annual total expenses:
$1.10B+$92.75M(+9.24%)Summary
- As of today (July 7, 2025), RARE annual total expenses is $1.10 billion, with the most recent change of +$92.75 million (+9.24%) on December 31, 2024.
- During the last 3 years, RARE annual total expenses has risen by +$363.06 million (+49.52%).
- RARE annual total expenses is now at all-time high.
Performance
RARE Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$282.23M-$4.92M(-1.71%)Summary
- As of today (July 7, 2025), RARE quarterly total expenses is $282.23 million, with the most recent change of -$4.92 million (-1.71%) on March 31, 2025.
- Over the past year, RARE quarterly total expenses has increased by +$8.05 million (+2.94%).
- RARE quarterly total expenses is now -10.62% below its all-time high of $315.77 million, reached on September 30, 2022.
Performance
RARE Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RARE Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.2% | +2.9% |
| 3 y3 years | +49.5% | +30.3% |
| 5 y5 years | +107.7% | +79.8% |
RARE Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.5% | -10.6% | +22.2% |
| 5 y | 5-year | at high | +107.7% | -10.6% | +126.2% |
| alltime | all time | at high | >+9999.0% | -10.6% | +5933.2% |
RARE Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $282.23M(-1.7%) |
| Dec 2024 | $1.10B(+9.2%) | $287.15M(+5.8%) |
| Sep 2024 | - | $271.48M(+3.1%) |
| Jun 2024 | - | $263.39M(-3.9%) |
| Mar 2024 | - | $274.18M(+9.9%) |
| Dec 2023 | $1.00B(-0.9%) | $249.44M(+2.6%) |
| Sep 2023 | - | $243.15M(-5.1%) |
| Jun 2023 | - | $256.27M(+0.7%) |
| Mar 2023 | - | $254.60M(+2.3%) |
| Dec 2022 | $1.01B(+38.1%) | $248.98M(-21.2%) |
| Sep 2022 | - | $315.77M(+36.7%) |
| Jun 2022 | - | $230.94M(+6.6%) |
| Mar 2022 | - | $216.57M(+16.5%) |
| Dec 2021 | $733.14M(+22.0%) | $185.95M(+8.4%) |
| Sep 2021 | - | $171.47M(+1.0%) |
| Jun 2021 | - | $169.75M(-17.6%) |
| Mar 2021 | - | $205.96M(+9.8%) |
| Dec 2020 | $601.15M(+13.9%) | $187.62M(+42.4%) |
| Sep 2020 | - | $131.78M(+5.6%) |
| Jun 2020 | - | $124.76M(-20.5%) |
| Mar 2020 | - | $156.97M(+20.7%) |
| Dec 2019 | $527.89M(+24.8%) | $130.04M(-9.6%) |
| Sep 2019 | - | $143.83M(+5.3%) |
| Jun 2019 | - | $136.62M(+16.4%) |
| Mar 2019 | - | $117.39M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $422.87M(+27.5%) | $106.60M(+5.1%) |
| Sep 2018 | - | $101.41M(-5.8%) |
| Jun 2018 | - | $107.69M(+0.5%) |
| Mar 2018 | - | $107.16M(+8.0%) |
| Dec 2017 | $331.55M(+33.6%) | $99.25M(+18.3%) |
| Sep 2017 | - | $83.91M(+7.0%) |
| Jun 2017 | - | $78.44M(+12.1%) |
| Mar 2017 | - | $69.95M(-0.9%) |
| Dec 2016 | $248.14M(+68.0%) | $70.55M(+7.1%) |
| Sep 2016 | - | $65.89M(+13.5%) |
| Jun 2016 | - | $58.07M(+8.3%) |
| Mar 2016 | - | $53.62M(-4.5%) |
| Dec 2015 | $147.74M(+160.2%) | $56.16M(+40.6%) |
| Sep 2015 | - | $39.94M(+32.5%) |
| Jun 2015 | - | $30.14M(+40.2%) |
| Mar 2015 | - | $21.50M(+26.9%) |
| Dec 2014 | $56.78M(+75.9%) | $16.94M(+7.0%) |
| Sep 2014 | - | $15.84M(+15.9%) |
| Jun 2014 | - | $13.66M(+32.1%) |
| Mar 2014 | - | $10.34M(+8.5%) |
| Dec 2013 | $32.28M(+101.9%) | $9.53M(+22.7%) |
| Sep 2013 | - | $7.76M(-5.9%) |
| Jun 2013 | - | $8.25M(+22.2%) |
| Mar 2013 | - | $6.75M(+44.2%) |
| Dec 2012 | $15.98M(+143.6%) | $4.68M |
| Dec 2011 | $6.56M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total expenses?
- What is the all time high annual total expenses for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual total expenses year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly total expenses year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total expenses?
The current annual total expenses of RARE is $1.10B
What is the all time high annual total expenses for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total expenses is $1.10B
What is Ultragenyx Pharmaceutical Inc. annual total expenses year-on-year change?
Over the past year, RARE annual total expenses has changed by +$92.75M (+9.24%)
What is Ultragenyx Pharmaceutical Inc. quarterly total expenses?
The current quarterly total expenses of RARE is $282.23M
What is the all time high quarterly total expenses for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total expenses is $315.77M
What is Ultragenyx Pharmaceutical Inc. quarterly total expenses year-on-year change?
Over the past year, RARE quarterly total expenses has changed by +$8.05M (+2.94%)